Glioblasztóma: vizsgálatok itt: Kína
58 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Phase I Clinical Study of YN003 in the Treatment of Glioma
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 50 worldwide
- Run by
- Beijing Inno Medicine Co., Ltd.
See details and how to joinNCT07929909 - 1/2. fázisNot yet taking people in KínaDLL3 CAR-T Therapy Targeting Brain Tumors
- Where
- Shenzhen
- Életkor
- 2 év to 70 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT07180927 - 1. fázisNot yet taking people in KínaImmune Modulatory DC Vaccine Against Brain Tumor
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 10
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03914768 - 1/2. fázisTaking peopleA Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
- Where
- Beijing, Chongqing, Guangzhou, Hangzhou, Hefei, Jinan, Nanning, Shenzhen, Xi’an, Zhuhai
- Életkor
- 18 év to 70 év
- People
- 42
- Run by
- Guangzhou Virotech Pharmaceutical Co., Ltd.
See details and how to joinNCT07093814 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Beijing, Hangzhou, Nanjing, Wuhan
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - 2. fázisTaking peopleA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
- Where
- Beijing, Chongqing, Jinan, Shanghai, Shenzhen, Wuhan
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- BioNTech SE
See details and how to joinNCT07297212 - 3. fázisTaking peopleSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 365 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT05303519 - 2/3. fázisNot yet taking people in KínaTris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07873996 - 1/2. fázisNot yet taking people in KínaEntacapone Plus Bevacizumab for Glioblastoma at First Recurrence
- Where
- Wenzhou
- Életkor
- 18 év and over
- People
- 96
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07831187 - 2. fázisNot yet taking people in KínaLevetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma
- Where
- Tianjin
- Életkor
- 18 év to 69 év
- People
- 140
- Run by
- Tianjin Medical University General Hospital
See details and how to joinNCT07758062 - 1/2. fázisTaking peopleA Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 40
- Run by
- Jecho Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07501559 - 1. fázisTaking peopleA Study of DEG6498 in Participants With Solid Tumors
- Where
- Beijing, Guangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Degron Therapeutics Co.
See details and how to joinNCT07244835 - 2. fázisTaking peopleIntensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 31
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07670026 - Korai 1. fázisTaking people[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 24
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07655869 - Korai 1. fázisTaking peopleDosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 5
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07648823 - No phaseTaking peopleMulticenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
- Where
- Changsha
- People
- 500
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT07608003 - No phaseTaking peopleNK Cell Therapy for Malignant Solid Brain Tumors
- Where
- Beijing, Qinhuangdao, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 27
- Run by
- Peking University Third Hospital
See details and how to joinNCT07552233 - No phaseTaking peopleSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 26
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07552467 - 1. fázisTaking peopleDual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Beijing Biotech
See details and how to joinNCT07551336 - Korai 1. fázisTaking peopleEvaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 10
- Run by
- Huashan Hospital
See details and how to joinNCT07538128 - 1/2. fázisTaking peopleBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 72
- Run by
- Beijing Biotech
See details and how to joinNCT07523529 - Korai 1. fázisCsak meghívásosClinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 9
- Run by
- Beijing Neurosurgical Institute
See details and how to joinNCT07520214 - 2. fázisTaking peopleProphylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 38
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07511725 - 1. fázisTaking peopleDual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Beijing Biotech
See details and how to joinNCT07480941 - 1. fázisNot yet taking people in KínaA Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
See details and how to joinNCT07455045